About this trial
Stereotactic body radiotherapy (SBRT) uses special equipment to accurately deliver a high dose of radiotherapy to the prostate in a smaller number of treatments. This study is being conducted to compare conventional radiotherapy (intensity modulated radiotherapy IMRT) over 4 weeks with SBRT over 1-2 weeks for patients with localised intermediate/high risk prostate cancer.
For patients with localised intermediate/high risk prostate cancer
Where’s this trial being run?
Beacon Hospital and Bon Secours Radiotherapy Cork in Partnership with UPMC Hillman Cancer Centre
Can I join this study / trial?
The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.
Why not Print this page and bring it with you. It will help your doctor and research team advise you.Print this page
For more detailed informationClick Here
The PACE Trial (Prostate Advances in Comparative Evidence) International randomised study of prostatectomy vs stereotactic body radiotherapy (SBRT) and conventional radiotherapy vs SBRT for organ-confined prostate cancer.
|Principal Investigator:||Prof. John Armstrong (Chief Investigator), Dr Alina Mihai (Beacon Hospital), Dr Paul Kelly (Bon Secours Radiotherapy Cork in Partnership with UPMC Hillman Cancer Centre)|
Cancer Trials Ireland
Ireland: February 2021
|Global Recruitment Target:||1182|
|Ireland Recruitment Target:|